ASML Holding Outlines Chipmaking Role, Growth Path Despite Analyst Uncertainty

ASML heads into its Q2 2026 earnings report, scheduled for July 15, with shares trading near record territory even after pulling back from the all-time high of €1,710 set on June 22 to around €1,582 . Wall Street sentiment has broadly turned more constructive: Goldman Sachs lifted its price target to €1,600 from €1,570 , while Wells Fargo raised its target to $2,200 from $1,750 and Bank of America moved to $2,345, citing AI-driven demand for the company's extreme ultraviolet (EUV) lithography systems . Still, some analysts have trimmed near-term upside expectations, reflecting lingering uncertainty over how much of that AI-fueled optimism is already priced in.

The caution is less about demand than about mix and geopolitics. ASML enters earnings with a €38.8 billion order backlog after a record €13.2 billion in Q4 2025 bookings, of which €7.4 billion came from EUV systems, coverage that now extends into 2027 . The company plans to ship roughly 60 EUV systems in 2026, about 25% more than in 2025, with capacity for as many as 80 systems by 2027, as memory makers such as SK Hynix and Micron ramp EUV-intensive capacity alongside logic customers, giving ASML a second growth engine beyond the traditional chipmaking cycle . China's share of system sales fell to 19% in Q1 2026 from 36% in the prior quarter, yet ASML still raised its full-year 2026 revenue guidance to a range of €36 billion to €40 billion, arguing that lost Chinese DUV volume is being offset by higher-margin EUV orders from Taiwan, Korea, and the US . That China exposure remains a live risk: U.S. lawmakers introduced the MATCH Act in early April, which would further restrict shipments of immersion DUV tools to China and could shave an estimated 5% off revenue if enacted .

Heading into the July 15 report, investors will be watching whether the bookings momentum from the fourth quarter carries into the first half of 2026, whether gross margin holds within the newly guided 51% to 53% band after posting 53.0% in Q1 , and whether management offers any clarity on the MATCH Act's legislative odds. With the stock still up roughly 60% year-to-date despite its recent pullback , the earnings call is likely to be treated as a test of whether ASML's AI-driven backlog and record bookings can keep outrunning the China-related headwinds that have periodically weighed on the stock over the past year.

Related Stocks

• ASML